Avid Bioservices Inc (CDMO)
8.25
+0.05
(+0.61%)
USD |
NASDAQ |
May 03, 16:00
8.23
-0.02
(-0.24%)
After-Hours: 20:00
Avid Bioservices Cash from Operations (TTM): 12.68M for Jan. 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| January 31, 2024 | 12.68M |
| October 31, 2023 | 2.047M |
| July 31, 2023 | -8.034M |
| April 30, 2023 | -12.89M |
| January 31, 2023 | -15.26M |
| October 31, 2022 | -3.122M |
| July 31, 2022 | 11.32M |
| April 30, 2022 | 9.465M |
| January 31, 2022 | 26.71M |
| October 31, 2021 | 26.71M |
| July 31, 2021 | 26.51M |
| April 30, 2021 | 31.18M |
| January 31, 2021 | 16.37M |
| October 31, 2020 | 10.54M |
| July 31, 2020 | 6.022M |
| April 30, 2020 | 5.827M |
| January 31, 2020 | 8.428M |
| October 31, 2019 | 5.982M |
| July 31, 2019 | -6.615M |
| April 30, 2019 | -11.60M |
| January 31, 2019 | -15.13M |
| October 31, 2018 | -20.68M |
| July 31, 2018 | -21.23M |
| April 30, 2018 | -25.99M |
| January 31, 2018 | -39.65M |
| Date | Value |
|---|---|
| October 31, 2017 | -41.85M |
| July 31, 2017 | -33.46M |
| April 30, 2017 | -39.17M |
| January 31, 2017 | -33.23M |
| October 31, 2016 | -29.80M |
| July 31, 2016 | -40.28M |
| April 30, 2016 | -39.59M |
| January 31, 2016 | -36.38M |
| October 31, 2015 | -38.44M |
| July 31, 2015 | -40.61M |
| April 30, 2015 | -36.02M |
| January 31, 2015 | -40.12M |
| October 31, 2014 | -38.80M |
| July 31, 2014 | -32.77M |
| April 30, 2014 | -28.25M |
| January 31, 2014 | -26.46M |
| October 31, 2013 | -24.88M |
| July 31, 2013 | -28.95M |
| April 30, 2013 | -20.93M |
| January 31, 2013 | -24.95M |
| October 31, 2012 | -26.88M |
| July 31, 2012 | -26.71M |
| April 30, 2012 | -35.88M |
| January 31, 2012 | -34.14M |
| October 31, 2011 | -32.38M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-15.26M
Minimum
Jan 2023
31.18M
Maximum
Apr 2021
8.099M
Average
8.428M
Median
Jan 2020
Cash from Operations (TTM) Benchmarks
| Emergent BioSolutions Inc | -206.30M |
| Creative Medical Technology Holdings Inc | -8.028M |
| Viking Therapeutics Inc | -54.87M |
| Stereotaxis Inc | -9.139M |
| MAIA Biotechnology Inc | -13.07M |